134 related articles for article (PubMed ID: 29516914)
1. The effects of thymoquinone and genistein treatment on telomerase activity, apoptosis, angiogenesis, and survival in thyroid cancer cell lines.
Ozturk SA; Alp E; Yar Saglam AS; Konac E; Menevse ES
J Cancer Res Ther; 2018; 14(2):328-334. PubMed ID: 29516914
[TBL] [Abstract][Full Text] [Related]
2. Antitumor and anti-angiogenesis effects of thymoquinone on osteosarcoma through the NF-κB pathway.
Peng L; Liu A; Shen Y; Xu HZ; Yang SZ; Ying XZ; Liao W; Liu HX; Lin ZQ; Chen QY; Cheng SW; Shen WD
Oncol Rep; 2013 Feb; 29(2):571-8. PubMed ID: 23232982
[TBL] [Abstract][Full Text] [Related]
3. Thymoquinone up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast cancer cells.
Arafa el-SA; Zhu Q; Shah ZI; Wani G; Barakat BM; Racoma I; El-Mahdy MA; Wani AA
Mutat Res; 2011 Jan; 706(1-2):28-35. PubMed ID: 21040738
[TBL] [Abstract][Full Text] [Related]
4. Targeting nuclear factor-kappa B activation pathway by thymoquinone: role in suppression of antiapoptotic gene products and enhancement of apoptosis.
Sethi G; Ahn KS; Aggarwal BB
Mol Cancer Res; 2008 Jun; 6(6):1059-70. PubMed ID: 18567808
[TBL] [Abstract][Full Text] [Related]
5. Genistein induces cell growth inhibition in prostate cancer through the suppression of telomerase activity.
Ouchi H; Ishiguro H; Ikeda N; Hori M; Kubota Y; Uemura H
Int J Urol; 2005 Jan; 12(1):73-80. PubMed ID: 15661057
[TBL] [Abstract][Full Text] [Related]
6. Thymoquinone inhibits the proliferation and invasion of esophageal cancer cells by disrupting the AKT/GSK-3β/Wnt signaling pathway via PTEN upregulation.
Ma J; Zhang Y; Deng H; Liu Y; Lei X; He P; Dong W
Phytother Res; 2020 Dec; 34(12):3388-3399. PubMed ID: 32901987
[TBL] [Abstract][Full Text] [Related]
7. Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells.
Jagadeesh S; Kyo S; Banerjee PP
Cancer Res; 2006 Feb; 66(4):2107-15. PubMed ID: 16489011
[TBL] [Abstract][Full Text] [Related]
8. Thymoquinone inhibits growth of human medulloblastoma cells by inducing oxidative stress and caspase-dependent apoptosis while suppressing NF-κB signaling and IL-8 expression.
Ashour AE; Ahmed AF; Kumar A; Zoheir KM; Aboul-Soud MA; Ahmad SF; Attia SM; Abd-Allah AR; Cheryan VT; Rishi AK
Mol Cell Biochem; 2016 May; 416(1-2):141-55. PubMed ID: 27084536
[TBL] [Abstract][Full Text] [Related]
9. Thymoquinone and cisplatin as a therapeutic combination in lung cancer: In vitro and in vivo.
Jafri SH; Glass J; Shi R; Zhang S; Prince M; Kleiner-Hancock H
J Exp Clin Cancer Res; 2010 Jul; 29(1):87. PubMed ID: 20594324
[TBL] [Abstract][Full Text] [Related]
10. Thymoquinone suppression of the human hepatocellular carcinoma cell growth involves inhibition of IL-8 expression, elevated levels of TRAIL receptors, oxidative stress and apoptosis.
Ashour AE; Abd-Allah AR; Korashy HM; Attia SM; Alzahrani AZ; Saquib Q; Bakheet SA; Abdel-Hamied HE; Jamal S; Rishi AK
Mol Cell Biochem; 2014 Apr; 389(1-2):85-98. PubMed ID: 24399465
[TBL] [Abstract][Full Text] [Related]
11. Thymoquinone enhances cisplatin-response through direct tumor effects in a syngeneic mouse model of ovarian cancer.
Wilson AJ; Saskowski J; Barham W; Yull F; Khabele D
J Ovarian Res; 2015 Jul; 8():46. PubMed ID: 26215403
[TBL] [Abstract][Full Text] [Related]
12. CKD712, a synthetic isoquinoline alkaloid, enhances the anti-cancer effects of paclitaxel in MDA-MB-231 cells through regulation of PTEN.
Kim YM; Tsoyi K; Jang HJ; Park EJ; Park SW; Kim HJ; Hwa JS; Chang KC
Life Sci; 2014 Sep; 112(1-2):49-58. PubMed ID: 25058922
[TBL] [Abstract][Full Text] [Related]
13. Thymoquinone induces cell death in human squamous carcinoma cells via caspase activation-dependent apoptosis and LC3-II activation-dependent autophagy.
Chu SC; Hsieh YS; Yu CC; Lai YY; Chen PN
PLoS One; 2014; 9(7):e101579. PubMed ID: 25000169
[TBL] [Abstract][Full Text] [Related]
14. Thymoquinone induces G2/M arrest, inactivates PI3K/Akt and nuclear factor-κB pathways in human cholangiocarcinomas both in vitro and in vivo.
Xu D; Ma Y; Zhao B; Li S; Zhang Y; Pan S; Wu Y; Wang J; Wang D; Pan H; Liu L; Jiang H
Oncol Rep; 2014 May; 31(5):2063-70. PubMed ID: 24603952
[TBL] [Abstract][Full Text] [Related]
15. Lack of p53 augments thymoquinone-induced apoptosis and caspase activation in human osteosarcoma cells.
Roepke M; Diestel A; Bajbouj K; Walluscheck D; Schonfeld P; Roessner A; Schneider-Stock R; Gali-Muhtasib H
Cancer Biol Ther; 2007 Feb; 6(2):160-9. PubMed ID: 17218778
[TBL] [Abstract][Full Text] [Related]
16. Anticancer effects of thymoquinone, caffeic acid phenethyl ester and resveratrol on A549 non-small cell lung cancer cells exposed to benzo(a)pyrene.
Ulasli SS; Celik S; Gunay E; Ozdemir M; Hazman O; Ozyurek A; Koyuncu T; Unlu M
Asian Pac J Cancer Prev; 2013; 14(10):6159-64. PubMed ID: 24289642
[TBL] [Abstract][Full Text] [Related]
17. Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-κB regulated gene products in multiple myeloma xenograft mouse model.
Siveen KS; Mustafa N; Li F; Kannaiyan R; Ahn KS; Kumar AP; Chng WJ; Sethi G
Oncotarget; 2014 Feb; 5(3):634-48. PubMed ID: 24504138
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of isoflavones on prostate cancer cells and PTEN gene.
Cao F; Jin TY; Zhou YF
Biomed Environ Sci; 2006 Feb; 19(1):35-41. PubMed ID: 16673816
[TBL] [Abstract][Full Text] [Related]
19. PTEN deficiency accelerates tumour progression in a mouse model of thyroid cancer.
Guigon CJ; Zhao L; Willingham MC; Cheng SY
Oncogene; 2009 Jan; 28(4):509-17. PubMed ID: 18997818
[TBL] [Abstract][Full Text] [Related]
20. Genistein inhibits MDA-MB-231 triple-negative breast cancer cell growth by inhibiting NF-κB activity via the Notch-1 pathway.
Pan H; Zhou W; He W; Liu X; Ding Q; Ling L; Zha X; Wang S
Int J Mol Med; 2012 Aug; 30(2):337-43. PubMed ID: 22580499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
